UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 527

Sortiert nach

A mechanism-based classification of pain in multiple sclerosis

Journal of neurology, 2013-02, Vol.260 (2), p.351-367

2013

Volltextzugriff (PDF)

An overview of pregnancy-related issues in patients with multiple sclerosis

European journal of neurology, 2015-10, Vol.22 (S2), p.34-39

2015

Volltextzugriff (PDF)

Oral ponesimod in relapsing–remitting multiple sclerosis: a randomised phase II trial

Journal of neurology, neurosurgery and psychiatry, 2014-11, Vol.85 (11), p.1198-1208

2014

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

European journal of neurology, 2011-09, Vol.18 (9), p.1122-1131

2011

Volltextzugriff (PDF)

One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis

European journal of neurology, 2009-11, Vol.16 (11), p.1202-1209

2009

Volltextzugriff (PDF)

A Combined Radiomics and Machine Learning Approach to Overcome the Clinicoradiologic Paradox in Multiple Sclerosis

American journal of neuroradiology : AJNR, 2021-11, Vol.42 (11), p.1927-1933

2021

Volltextzugriff (PDF)

Natalizumab discontinuation and disease restart in pregnancy: a case series

Acta neurologica Scandinavica, 2015-05, Vol.131 (5), p.336-340

2015

Volltextzugriff (PDF)

Sex hormones, brain damage and clinical course of Multiple Sclerosis

Journal of the neurological sciences, 2009-11, Vol.286 (1), p.35-39

2009

Volltextzugriff (PDF)

Functional connectivity changes and their relationship with clinical disability and white matter integrity in patients with relapsing–remitting multiple sclerosis

Multiple sclerosis, 2015-11, Vol.21 (13), p.1681-1692

2015

Volltextzugriff (PDF)

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity

Journal of neurology, neurosurgery and psychiatry, 2016-09, Vol.87 (9), p.944-951

2016

Volltextzugriff (PDF)

Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up

Neurology, 2010-09, Vol.75 (13), p.1134

2010

Volltextzugriff (PDF)

Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis

Multiple sclerosis, 2015-09, Vol.21 (10), p.1291-1297

2015

Volltextzugriff (PDF)

Breastfeeding is not related to postpartum relapses in multiple sclerosis

Neurology, 2011-07, Vol.77 (2), p.145

2011

Volltextzugriff (PDF)

Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience

Journal of neurology, 2019-02, Vol.266 (2), p.411-416

2019

Volltextzugriff (PDF)

Pulse monthly steroids during an elective interruption of natalizumab: a post-marketing study

European journal of neurology, 2012-05, Vol.19 (5), p.783-787

2012

Volltextzugriff (PDF)

Cognitive and psychosocial features of childhood and juvenile MS

Neurology, 2008-05, Vol.70 (20), p.1891

2008

Volltextzugriff (PDF)

Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis

Multiple sclerosis, 2007-07, Vol.13 (6), p.783-791

2007

Volltextzugriff (PDF)

Survey of diagnostic and treatment practices for multiple sclerosis in Europe

European journal of neurology, 2017-03, Vol.24 (3), p.516-522

2017

Volltextzugriff (PDF)

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis

Neurology, 2010-11, Vol.75 (20), p.1794

2010

Volltextzugriff (PDF)

Corpus callosum microstructural changes associated with Kawashima Nintendo Brain Training in patients with multiple sclerosis

Journal of the neurological sciences, 2016-11, Vol.370, p.211-213

2016

Volltextzugriff (PDF)

Guidelines on use of anti-IFN-β antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-β antibodies in multiple sclerosis

European journal of neurology, 2005-11, Vol.12 (11), p.817-827

2005

Volltextzugriff (PDF)

Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management

European journal of neurology, 2018-05, Vol.25 (5), p.739-746

2018

Volltextzugriff (PDF)

Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials

Neurology, 2004-11, Vol.63 (10), p.1779

2004

Volltextzugriff (PDF)

Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis

Clinical rehabilitation, 2007-04, Vol.21 (4), p.331-337

2007

Volltextzugriff (PDF)

Real-life impact of early interferonβ therapy in relapsing multiple sclerosis

Annals of neurology, 2009-10, Vol.66 (4), p.513-520

2009

Volltextzugriff (PDF)

1 – 25 von 527

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(492)
Mit Volltextzugriff
(433)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Multiple Sclerosis
(48)
Neurology
(32)
Journal Of The Neurological Sciences
(30)
Diabetologia
(23)
Neurological Sciences
(19)
European Journal Of Neurology
(18)
Journal Of Neurology
(17)
Journal Of Neuroimmunology
(16)
Journal Of Neurology, Neurosurgery And Psychiatry
(16)
The Lancet
(16)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A mechanism-based classification of pain in multiple sclerosis

An overview of pregnancy-related issues in patients with multiple sclerosis

Oral ponesimod in relapsing–remitting multiple sclerosis: a randomised phase II trial

A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis

A Combined Radiomics and Machine Learning Approach to Overcome the Clinicoradiologic Paradox in Multiple Sclerosis

Natalizumab discontinuation and disease restart in pregnancy: a case series

Sex hormones, brain damage and clinical course of Multiple Sclerosis

Functional connectivity changes and their relationship with clinical disability and white matter integrity in patients with relapsing–remitting multiple sclerosis

Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity

Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up

Parity is associated with a longer time to reach irreversible disability milestones in women with multiple sclerosis

Breastfeeding is not related to postpartum relapses in multiple sclerosis

Discontinuation of teriflunomide and dimethyl fumarate in a large Italian multicentre population: a 24-month real-world experience

Pulse monthly steroids during an elective interruption of natalizumab: a post-marketing study

Cognitive and psychosocial features of childhood and juvenile MS

Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis

Survey of diagnostic and treatment practices for multiple sclerosis in Europe

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis

Corpus callosum microstructural changes associated with Kawashima Nintendo Brain Training in patients with multiple sclerosis

Guidelines on use of anti-IFN-β antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-β antibodies in multiple sclerosis

Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general management

Interferon beta-1b in secondary progressive MS: a combined analysis of the two trials

Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis

Real-life impact of early interferonβ therapy in relapsing multiple sclerosis

Suchergebnisse filtern